• Latest Posts

Evotec completes acquisition of Rigenerand

Funding doubled for company working on breakthrough auto-immune disease therapeutics

Drug for childhood arthritis gets expanded approvals in the EU

Watch: Antibody Analytics opens new health sciences center

Study reveals progress for those with hepatitis B

Evaxion Biotech picks candidate for lung cancer trial

ADVERTISEMENT

Roquefort Therapeutics buys UK biotech in return for shares

Drug to treat esophageal cancer approved in China

ImCheck raises €96M in funding round

Sponsored by 7 Jun 2022

Gene therapy: can CDMOs solve the manufacturing bottleneck?

Duke Street Bio enters stage with next-generation cancer therapies

Immunocore Approvals Open Door for TCR Cancer Drugs

ADVERTISEMENT